| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 03/23/2006 | US20060063749 immunomoderators ; bromo-3-hydroxyandrostan-17-one; antiallergens; rhinitis |
| 03/22/2006 | EP1636249A1 Target-oriented chemotherapy for treating tumors of the sexual organs |
| 03/21/2006 | US7015211 steroids formulated in topical dosage form, as creams, gels or suppositories used for therapy or prohylaxis of symptoms associated with menopause |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2062792C Treatment of androgen-related diseases |
| 03/16/2006 | WO2006027347A1 15β-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY |
| 03/16/2006 | WO2004085458A3 Steroid spirolactonization |
| 03/16/2006 | US20060058271 Methods for screening, studying, and treating dissorders with a component of mercurial toxicity |
| 03/16/2006 | DE102004035808A1 Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen Ammonium salts and ammonium salt Mineralsalzchlatrate as transport and active form for pharmaceutical and medical-phase transfer agent for chemical applications |
| 03/15/2006 | EP1633771A1 Macrolide-conjugates with anti-inflammatory activity |
| 03/15/2006 | EP1633367A2 Antiangiogenic agents |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/08/2006 | EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/07/2006 | US7009063 Process for the production of oxandrolone |
| 03/02/2006 | WO2006021554A1 Process for the preparation of estrone and/or estradiol-derivates |
| 03/01/2006 | EP1629085A2 Transfection agents |
| 03/01/2006 | EP1628624A2 Methods and compositions for interferon therapy |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 02/23/2006 | US20060041151 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex |
| 02/23/2006 | US20060040344 Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs |
| 02/21/2006 | US7002028 fungal method for 7 beta - and 11 alpha -hydroxylation of 5-androsten-3 beta -ol-17-one to yield 5-androsten-3 beta, 7 beta, 11 alpha-triol-17-one; pharmaceuticals |
| 02/15/2006 | CN1735627A Synthesis of estetrol via estrone derived steroids |
| 02/09/2006 | US20060030552 such as fulvestrant |
| 02/09/2006 | CA2574967A1 A process for the preparation of 7.alpha.-alkylated 19-norsteroids |
| 02/08/2006 | EP1622926A2 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 02/08/2006 | EP1622924A2 8$g(b)-vinyl-11$g(b)-( g(v)-substituted)alkyl-estra-1,3,5(10)-trienes |
| 02/08/2006 | EP1059977B1 Recovery of organic solutes from aqueous solutions |
| 02/07/2006 | US6995278 Antiangiogenic agents |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/02/2006 | US20060025619 Methods of using 2-methoxyestradiol of high purity |
| 02/02/2006 | US20060025394 Estradiol-related compounds and methods of use as anti-tumor agents |
| 02/02/2006 | CA2570994A1 Estrogen receptor modulators |
| 02/01/2006 | EP1621199A1 Remedies for diseases to be applied to eye |
| 02/01/2006 | CN1729002A Exemestane as chemopreventing agent |
| 01/31/2006 | US6992075 dehydrogenating estrogenic salts by heating in high humidity to produce conjugated estrogen salts; 14-hydroxy (or hydroperoxy)- Delta 8,9-Dehydroestrone Sodium Sulfate; side effect reduction; hormone replacement therapy |
| 01/26/2006 | DE102004032674A1 Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1 New 2-substituted estra-1,3,5 (10) triene-17-one 17β-hydroxysteroid dehydrogenase inhibitors of type 1 |
| 01/25/2006 | EP1618882A2 Estrogen compositions for neuroprotection |
| 01/25/2006 | CN1724557A Preparation method of 9 alpha, 11 alpha-epoxy-17 beta-hydroxy-3-oxy-17 alpha pregn-4-olefine-7 alpha, 21-diformic acid gammalactone 7-methyl ester |
| 01/24/2006 | US6989378 novel androgen (7 alpha ,17 beta )-7-methyl-17-[(1-oxoundecyl)oxy]estr-4en-3one); oil solubility; suitable for administration by means of injection; for male contraception |
| 01/19/2006 | WO2006005611A2 Glucocorticoid 16alpha,17.alpha.-isoxazolidines as anti-inflammatory agents |
| 01/19/2006 | US20060014973 Processes for the preparation of 16beta-alkoxy, 17alpha-hydroxy steroids and steroidal 16beta, 17alpha-diols from 16alpha, 17alpha-epoxy steroids |
| 01/19/2006 | CA2573405A1 Organic compounds |
| 01/18/2006 | EP1615944A2 Antiandrogens with marginal agonist activity and methods of use |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/12/2006 | US20060009434 e.g. 3-Hydroxy-2-phenylethinyl-estra-1,3,5(10)-trien-17-one 19; anticarcinogenic, antitumor agent; hormone-dependent tumor disease of a male/female reproductive gland or endometriosis; estrogen-dependent diseases |
| 01/12/2006 | US20060009431 Nitrosated and nitrosylated compounds, compositions and methods use |
| 01/10/2006 | CA2120004C Methylating or ethylating agent and process for 1,4-adding a methyl or ethyl group to an .alpha.,.beta.-unsaturated ketone group |
| 01/05/2006 | US20060003974 Bile acid derived steroidal dimers with amphiphilic topology having antiproliferative activity |
| 01/04/2006 | CN1234721C Androgenic 7-substituted 11-halogen steroids |
| 01/03/2006 | US6982329 provides synthetic methodology that may be employed to prepare steroid compounds having specified chemical functionality; steroids containing cyclohexene moiety are oxidized to corresponding alpha , beta -unsaturated ketone |
| 12/29/2005 | WO2005123757A1 Estrogen receptor modulators |
| 12/29/2005 | US20050288268 Preparation of 6-hydroxyequilenins |
| 12/29/2005 | US20050288267 Estradiol prodrugs |
| 12/29/2005 | US20050288264 Dosage Regimen and Pharmaceutical Composition for Emergency Contraception |
| 12/29/2005 | US20050287619 Method and reagent for measuring cholesterol in high-density lipoproteins |
| 12/29/2005 | CA2569152A1 Estrogen receptor modulators |
| 12/28/2005 | EP1608670A1 Process for the production of tibolone |
| 12/28/2005 | CN1713915A Methods for preventing and treating bone loss with steroid compounds |
| 12/28/2005 | CN1712410A Extraction of 4-androstenedione from oil phase of fermenting liquid |
| 12/22/2005 | WO2005089256A3 Antiangiogenic agents |
| 12/22/2005 | US20050282793 Steroid prodrugs with androgenic action |
| 12/22/2005 | US20050282732 immunology moderator; -bromoo-3-hydroxyandrostan-17-one with excipients; prevent viral reproduction |
| 12/21/2005 | EP1606306A2 Steroid spirolactonization |
| 12/21/2005 | EP1490391B1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position |
| 12/21/2005 | EP1144431B1 16-hydroxyestratrienes as selective estrogens |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/15/2005 | WO2005030120A3 Antiangiogenic agents |
| 12/15/2005 | US20050277625 Estriol and estetrol prodrugs |
| 12/14/2005 | EP1603933A2 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 12/07/2005 | EP1430073B1 Solvent extraction process |
| 12/06/2005 | US6972169 Fungal degradation and bioremediation system for CCA-treated wood |
| 11/29/2005 | US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/23/2005 | EP1060744B1 Preventives/remedies for osteoporosis |
| 11/23/2005 | EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition |
| 11/23/2005 | CN1700920A Phophylactic and therapeutic use of hydroxysteroids |
| 11/22/2005 | US6967255 Phenanthrene compounds |
| 11/17/2005 | US20050256095 using 6-bromo-3-hydroxtandrostan-17-one |
| 11/17/2005 | US20050256094 especially those of the 20-spiroxane series; 11,12-epoxy steroid, 4,5-9,11-diepoxy steroid and 12-keto intermediates; Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-,?-lactone, methyl ester, (7a,11a,17a)-; eplerenone or epoxymexrenone; minimum of isolation steps |
| 11/16/2005 | EP1594887A2 Novel steroids and steroid mimetics, method for the production and use thereof |
| 11/16/2005 | EP1594481A2 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents |
| 11/16/2005 | CN1227011C Method of treating adenosine depletion |
| 11/15/2005 | US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 11/15/2005 | US6964953 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 11/10/2005 | US20050250751 neo-tanshinlactone is excluded; treating cancer |
| 11/10/2005 | US20050250749 Helix 12 directed pharmaceutical products |
| 11/09/2005 | CN1694964A Method and reagent for measuring cholesterol in high-density lipoproteins |
| 11/09/2005 | CN1694897A Processes for preparing 7-carboxy substituted steroids |
| 11/09/2005 | CN1694896A Processes for preparing C-7 substituted 5-androstenes |
| 11/03/2005 | US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator |
| 11/02/2005 | EP1590668A2 Screeninig and treatment methods for prevention of preterm delivery |
| 11/02/2005 | CN1692122A New etonogestrel esters |
| 10/26/2005 | EP1501859B1 17a-FLUOROALKYL-11BETA-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS |
| 10/26/2005 | CN1687102A Steroid framework compound, synthesizing process and its use |
| 10/25/2005 | US6958327 18 Norsteroids as selectively active estrogens |
| 10/20/2005 | US20050234251 Process and new intermediates for the preparation of steroids with a progestogen activity |
| 10/20/2005 | US20050234232 Novel compositions for the delivery of negatively charged molecules |